SCHEMBL30392744

SCHEMBL30392744

CC(C)(C)OC(=O)N1CCC2(CC1)CCN(C(=O)c1cccc(N3CCC(=O)NC3=O)c1)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 4/20 0.51
▸ DDB1 Q16531 3/20 0.50
▸ USP30 Q70CQ3 1/20 0.46
▸ GABRD O14764 2/20 0.44
▸ GABRA1 P14867 2/20 0.44
▸ GABRB1 P18505 2/20 0.44
▸ GABRA5 P31644 2/20 0.44
▸ GABRA3 P34903 2/20 0.44
▸ GABRA2 P47869 2/20 0.44
▸ GABRB2 P47870 2/20 0.44
▸ GABRA4 P48169 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ EPHX2 P34913 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23173797 0.94 CRBN (0.56) CRBNDDB1USP30ALDH1A1TSHR
SCHEMBL23123218 0.88 CRBN (0.49) CRBNDDB1USP30EPHX2
SCHEMBL30009143 0.88 CRBN (0.49) CRBNDDB1USP30EPHX2
SCHEMBL30874149 0.83 ACACB (0.45) CRBNDDB1GABRDGABRA1GABRB1
SCHEMBL21427524 0.83 GABRD (0.61) CRBNDDB1GABRDGABRA1GABRB1
SCHEMBL30392489 0.83 GABRD (0.61) CRBNDDB1GABRDGABRA1GABRB1
SCHEMBL27148853 0.83 CRBN (0.46) CRBNDDB1USP30EPHX2
SCHEMBL26509089 0.83 MEN1 (0.46) CRBNDDB1ALDH1A1MEN1CYP1A2
SCHEMBL30148829 0.82 CRBN (0.42) CRBNDDB1ALDH1A1TSHRMEN1
SCHEMBL29265203 0.81 CRBN (0.55) CRBNDDB1USP30ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423086-A1 TYK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-09-04 — — EP disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback